Set to go live from May 15, the mutual market derivatives initiative marks a world first for international trading that is set to facilitate the increased internationalisation of renminbi.
Based on bespoke research with investors, professionals active in life sciences and healthcare, and advisors who help in the dealmaking process, as well as an in-depth study of recent trends in the space, the Life Sciences & Healthcare Report 2023 from FinanceAsia in partnership with DFIN offers a succinct and yet comprehensive overview of the investible opportunity in a critical sector.
Starting in 2018, Hong Kong-based NWD has taken several globally pioneering steps to lead the way when it comes to sustainable finance and development in Asia.